Articles with public access mandates - Mackenzie CottrellLearn more
Not available anywhere: 6
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy
J Blazkova, F Gao, MH Marichannegowda, JS Justement, V Shi, ...
Nature Medicine 27 (11), 1893-1898, 2021
Mandates: US National Institutes of Health
Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine …
S Scévola, A Imaz, ML Cottrell, J Niubo, B Van Horne, J Tiraboschi, ...
Clinical Infectious Diseases 75 (11), 2012-2015, 2022
Mandates: US National Institutes of Health, Government of Spain
Optimising oral PrEP while awaiting long-acting cabotegravir
S McCormack, ML Cottrell
The Lancet HIV 10 (11), e694-e695, 2023
Mandates: UK Medical Research Council
Genital Microbiome, Inflammation, and Tenofovir Levels in Transgender Men and Cisgender Women Taking Oral PrEP
E Hastie, MS Srivatsa, S Gianella, M Cottrell, K Forsyth, M Porrachia, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes, 10.1097, 2022
Mandates: US National Institutes of Health, US Department of Veterans Affairs
A quantitative LC–MS/MS method for the determination of tissue brincidofovir and cidofovir diphosphate in a MuPyV‐infected mouse model
BB Guzman, AP Schauer, JA Dunn, ML Cottrell, C Sykes
Biomedical Chromatography 35 (5), e5061, 2021
Mandates: US National Institutes of Health
The potential pitfalls of PrEP
ML Cottrell, JB Dumond
The Lancet HIV 6 (1), e6-e8, 2019
Mandates: US National Institutes of Health
Available somewhere: 61
Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir
ML Cottrell, T Hadzic, ADM Kashuba
Clinical pharmacokinetics 52, 981-994, 2013
Mandates: US National Institutes of Health
A translational pharmacology approach to predicting outcomes of preexposure prophylaxis against HIV in men and women using tenofovir disoproxil fumarate with or without …
ML Cottrell, KH Yang, HMA Prince, C Sykes, N White, S Malone, ...
The Journal of infectious diseases 214 (1), 55-64, 2016
Mandates: US National Institutes of Health
Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery
SR Benhabbour, M Kovarova, C Jones, DJ Copeland, R Shrivastava, ...
Nature communications 10 (1), 4324, 2019
Mandates: US National Institutes of Health
Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues
ML Cottrell, KL Garrett, HMA Prince, C Sykes, A Schauer, CW Emerson, ...
Journal of Antimicrobial Chemotherapy 72 (6), 1731-1740, 2017
Mandates: US National Institutes of Health
Decreased tenofovir diphosphate concentrations in a transgender female cohort: implications for human immunodeficiency virus preexposure prophylaxis
ML Cottrell, HMA Prince, AP Schauer, C Sykes, K Maffuid, A Poliseno, ...
Clinical Infectious Diseases 69 (12), 2201-2204, 2019
Mandates: US National Institutes of Health
Smartphone-based contingency management intervention to improve pre-exposure prophylaxis adherence: pilot trial
JT Mitchell, S LeGrand, LB Hightow-Weidman, MS McKellar, ...
JMIR mHealth and uHealth 6 (9), e10456, 2018
Mandates: US National Institutes of Health
Pharmacokinetics of antiretrovirals in mucosal tissue
ML Cottrell, N Srinivas, ADM Kashuba
Expert opinion on drug metabolism & toxicology 11 (6), 893-905, 2015
Mandates: US National Institutes of Health
Topical microbicides and HIV prevention in the female genital tract
ML Cottrell, ADM Kashuba
The Journal of Clinical Pharmacology 54 (6), 603-615, 2014
Mandates: US National Institutes of Health
Safety and pharmacokinetics of a tenofovir alafenamide fumarate-emtricitabine based oral antiretroviral regimen for prevention of HIV acquisition in women: a randomized …
AR Thurman, JL Schwartz, ML Cottrell, V Brache, BA Chen, L Cochón, ...
EClinicalMedicine 36, 2021
Mandates: US National Institutes of Health, US Agency for International Development
Validation of an LC–MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots
AP Schauer, C Sykes, ML Cottrell, H Prince, ADM Kashuba
Journal of pharmaceutical and biomedical analysis 149, 40-45, 2018
Mandates: US National Institutes of Health
A translational pharmacology approach to predicting HIV pre-exposure prophylaxis outcomes in men and women using tenofovir disoproxil fumarate+/-emtricitabine
ML Cottrell, KH Yang, HMA Prince, C Sykes, N White, S Malone
J Infect Dis 214 (1), 55-64, 2016
Mandates: US National Institutes of Health
A spatio-temporal assessment of simian/human immunodeficiency virus (SHIV) evolution reveals a highly dynamic process within the host
AF Feder, C Kline, P Polacino, M Cottrell, ADM Kashuba, BF Keele, SL Hu, ...
PLoS pathogens 13 (5), e1006358, 2017
Mandates: US National Science Foundation, US National Institutes of Health
Long-acting biodegradable implant for sustained delivery of antiretrovirals (ARVs) and hormones
L Li, GJ Gatto, RM Brand, SA Krovi, ML Cottrell, C Norton, ...
Journal of Controlled Release 340, 188-199, 2021
Mandates: US Agency for International Development
Antiretroviral therapy concentrations differ in gut vs. lymph node tissues and are associated with HIV viral transcription by a novel RT-ddPCR assay
SA Lee, S Telwatte, H Hatano, ADM Kashuba, ML Cottrell, R Hoh, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 83 (5), 530-537, 2020
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program